These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17165896)

  • 21. [Synthesis and pharmacologic action of chiral fomocaine ((4-[2-methyl-3-(morpholin-4-yl)propyl)benzyl)-phenyl-ether and (4-(1-methyl-3-(morpholin-4-yl)propyl]benzyl)-phenyl-ether). 13. Synthesis of new compounds with local anesthetic action].
    Oelschläger H; Glassl P; Seeling A; Wange J; Listing M; Jung B
    Pharmazie; 2001 Aug; 56(8):620-5. PubMed ID: 11534337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK).
    Hollick JJ; Golding BT; Hardcastle IR; Martin N; Richardson C; Rigoreau LJ; Smith GC; Griffin RJ
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3083-6. PubMed ID: 12941339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structural elucidation and DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8-mono and 7, 8-di-substituted]-1,3-benzoxazines.
    Ihmaid S; Al-Rawi J; Bradley C
    Eur J Med Chem; 2010 Nov; 45(11):4934-46. PubMed ID: 20800933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
    Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
    Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chiral synthesis of (2S,3S)-2-(2-morpholin-2-yl-2-phenylmethoxy)phenol.
    Prabhakaran J; Majo VJ; Mann JJ; Kumar JS
    Chirality; 2004 Mar; 16(3):168-73. PubMed ID: 14770413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor.
    Chao Q; Sprankle KG; Grotzfeld RM; Lai AG; Carter TA; Velasco AM; Gunawardane RN; Cramer MD; Gardner MF; James J; Zarrinkar PP; Patel HK; Bhagwat SS
    J Med Chem; 2009 Dec; 52(23):7808-16. PubMed ID: 19754199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors.
    Payne SL; Rodriguez-Aristegui S; Bardos J; Cano C; Golding BT; Hardcastle IR; Peacock M; Parveen N; Griffin RJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3649-53. PubMed ID: 20472428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel chromene scaffolds for adenosine receptors.
    Costa M; Areias F; Castro M; Brea J; Loza MI; Proença F
    Org Biomol Chem; 2011 Jun; 9(11):4242-9. PubMed ID: 21509353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of a potent and selective inhibitor of p90 Rsk.
    Maloney DJ; Hecht SM
    Org Lett; 2005 Mar; 7(6):1097-9. PubMed ID: 15760148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting DNA-Dependent Protein Kinase for Cancer Therapy.
    Harnor SJ; Brennan A; Cano C
    ChemMedChem; 2017 Jun; 12(12):895-900. PubMed ID: 28423228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.
    Bandarage U; Hare B; Parsons J; Pham L; Marhefka C; Bemis G; Tang Q; Moody CS; Rodems S; Shah S; Adams C; Bravo J; Charonnet E; Savic V; Come JH; Green J
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5191-4. PubMed ID: 19632115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 2-perfluoroalkyl 4H- and 2H-chromenylphosphonates mediated by amines and phosphines.
    Duda B; Tverdomed SN; Röschenthaler GV
    J Org Chem; 2011 Jan; 76(1):71-9. PubMed ID: 21121658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361.
    Wong WW; Jackson RK; Liew LP; Dickson BD; Cheng GJ; Lipert B; Gu Y; Hunter FW; Wilson WR; Hay MP
    Biochem Pharmacol; 2019 Nov; 169():113641. PubMed ID: 31541630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase.
    Nowak P; Cole DC; Brooijmans N; Bursavich MG; Curran KJ; Ellingboe JW; Gibbons JJ; Hollander I; Hu Y; Kaplan J; Malwitz DJ; Toral-Barza L; Verheijen JC; Zask A; Zhang WG; Yu K
    J Med Chem; 2009 Nov; 52(22):7081-9. PubMed ID: 19848404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides.
    Chan C; Borthwick AD; Brown D; Burns-Kurtis CL; Campbell M; Chaudry L; Chung CW; Convery MA; Hamblin JN; Johnstone L; Kelly HA; Kleanthous S; Patikis A; Patel C; Pateman AJ; Senger S; Shah GP; Toomey JR; Watson NS; Weston HE; Whitworth C; Young RJ; Zhou P
    J Med Chem; 2007 Apr; 50(7):1546-57. PubMed ID: 17338508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective and dual action orally active inhibitors of thrombin and factor Xa.
    Young RJ; Brown D; Burns-Kurtis CL; Chan C; Convery MA; Hubbard JA; Kelly HA; Pateman AJ; Patikis A; Senger S; Shah GP; Toomey JR; Watson NS; Zhou P
    Bioorg Med Chem Lett; 2007 May; 17(10):2927-30. PubMed ID: 17420122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
    Pritchard KM; Al-Rawi J; Bradley C
    Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of practical methodologies for the synthesis of novel 3(4-oxo-4H-chromen-3-yl)acrylic acid hydrazides.
    Joshi RS; Mandhane PG; Badadhe PV; Gill CH
    Ultrason Sonochem; 2011 May; 18(3):735-8. PubMed ID: 21112230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (+/-)-(4-Oxo-4H-chromen-2-yl)(phenyl)methyl acetate.
    Małecka M; Massa W; Budzisz E
    Acta Crystallogr C; 2004 Oct; 60(Pt 10):o762-4. PubMed ID: 15467152
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.